Induced pluripotent stem cells: An emerging theranostics platform

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations


Nuclear reprogramming generates induced pluripotent stem (iPS) cells endowed with the unlimited potential to reconstruct genetically identical tissues. This biomedical tool offers unprecedented opportunities to develop scalable yet personalized cell-based reagents. The emerging platform of regenerative theranostics provides a unique approach to expose mechanisms of disease etiology in the context of dysfunctional cell biology. Resolved molecular dynamics that define and regulate the regenerative capacity of individual stem cells will enable next-generation, patient-specific diagnostic and therapeutic applications.

Original languageEnglish (US)
Pages (from-to)648-650
Number of pages3
JournalClinical pharmacology and therapeutics
Issue number5
StatePublished - May 2011

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Induced pluripotent stem cells: An emerging theranostics platform'. Together they form a unique fingerprint.

Cite this